BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 22, 2025
See today's BioWorld
Home
» Another biopharma joins IPO queue as Biohaven seeks $100M raise
To read the full story,
subscribe
or
sign in
.
Another biopharma joins IPO queue as Biohaven seeks $100M raise
April 11, 2017
By
Marie Powers
Biohaven Pharmaceutical Holding Co. Ltd., a clinical-stage biopharma registered in the British Virgin Islands, filed an S-1 with the SEC for an IPO of up to $100 million.
BioWorld
